A separate risk pool for customers who purchase insurance from the Affordable Care Act (ACA) exchanges during the special enrollment period could help stabilize the market, argued former Aetna CEO and chairman Ronald Williams.

The price of EpiPens, an injectable treatment for serious allergic reactions, has increased by more than 400 percent in the last nine years, and two U.S. Senators are asking the device manufacturer and federal regulators to explain why.

U.S. lawmakers are joining concerned parents in demanding to know: What is up with the sudden increase in the price of an EpiPen? 

Medical device companies will pay the FDA nearly $1 billion in user fees for five years beginning in October 2017 under the fourth reauthorization of the Medical Device User Fee & Modernization Act (MDUFA).

Medical device companies will pay the FDA nearly $1 billion in user fees for five years beginning in October 2017 under the fourth reauthorization of the Medical Device User Fee & Modernization Act (MDUFA).

The U.S. should brace itself for even more Zika headaches, according to the National Institutes of Health (NIH), because the virus could be around for a while and spread to even more areas. One study found it could be even more harmful than scientists originally believed.   

State governments may be profiting off Medicaid funds meant for hospitals that are publicly-owned but managed privately, according to a report from HHS’s Office of Inspector General (OIG).

Although the Affordable Care Act provided health insurance to many people throughout the country, some are still stuck without insurance, particularly those in southern states.